FDA Clearance Tracker · P240035
ETHIZIA
Last checked: Nov 19, 2026Latest source record: Dec 15, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 15, 2025
Approved
Time to decision
424 days
Received Oct 17, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240035
- Device name
- ETHIZIA
- Applicant
- ETHICON, Inc.
- Applicant location
- Raritan, NJ
- Received
- Oct 17, 2024
- Decided
- Dec 15, 2025
- Decision
- Approved
- Supplements
- 6 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
Approval for ETHIZIA indicated for use in adult patients with a body weight of greater than or equal to 25kg as an adjunct to hemostasis in open liver surgery for minimal, mild, or moderate bleeding sites when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SGV (Agent, absorbable hemostatic, collagen with polymeric additives).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for ETHICON, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253394 · Decided Jun 25, 2026 · 268 days after receipt
Device type: Suture, Absorbable, Synthetic, Polyglycolic Acid (GAM) · General & Plastic Surgery
- ETHIZIA Hemostatic PatchPMA supplement
P240035-S002 · Decided Jun 25, 2026 · 178 days after receipt · Panel Track
Device type: Agent, absorbable hemostatic, collagen with polymeric additives (SGV) · General & Plastic Surgery
K252047 · Decided May 18, 2026 · 322 days after receipt
Device type: Suture, Surgical, Absorbable, Polydioxanone (NEW) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.